Cytek Biosciences, Inc. CTKB Business Segments — Total revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s business segments — total revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s business segments — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported business segments — total revenue, net of $44.14M in Q1 2026.
- How has Cytek Biosciences, Inc.'s business segments — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s business segments — total revenue, net increased by 6.5% year-over-year, from $41.46M to $44.14M.
- What is the long-term trend for Cytek Biosciences, Inc.'s business segments — total revenue, net?
- Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s business segments — total revenue, net has grown at a 7.1% compound annual growth rate (CAGR), from $164.04M to $201.49M.
- What does business segments — total revenue, net mean?
- Represents the total net sales generated by the primary business segment after deducting returns, allowances, and discounts. This figure serves as the top-line indicator of market demand for the company's core products and services.